Cell-cycle targeted therapies
- 1 January 2004
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 5 (1) , 27-36
- https://doi.org/10.1016/s1470-2045(03)01321-4
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest pointsThe FASEB Journal, 2003
- Loss of p16Ink4a confers susceptibility to metastatic melanoma in miceNature, 2001
- Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesisNature, 2001
- Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19Cell, 1997
- New functional activities for the p21 family of CDK inhibitors.Genes & Development, 1997
- Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrestCell, 1995
- A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human MelanomaScience, 1995
- Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16Nature, 1995
- Cell Cycle Control and CancerScience, 1994
- A Restriction Point for Control of Normal Animal Cell ProliferationProceedings of the National Academy of Sciences, 1974